ACTUATE THERAPEUTICS, INC. (ACTU) insider trading
ACTUATE THERAPEUTICS, INC. insiders have made 1 open-market purchase worth $50k since Oct 29, 2026, by 1 insider. The latest: Daniel M. Schmitt (President) bought $50k, filed Oct 29, 2026, scored 40 out of 100.
Follow ACTU, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 29 Form 4 (opens sec.gov) |
Daniel M. SchmittPresidentPresident · Near 52-week low · Penny stock: hard to trade | +47% stake | 40 | $50k 140,844 at $0.35 |
waiting | waiting |
Investors with more than 5% of ACTU (13D and 13G)
| Filed | Investor | Kind | Stake |
|---|---|---|---|
| Oct 30 13G | Hexstone Capital LLC | Passive | 7.7% |
A 13D is filed by an investor who may push for change; a 13G by a passive one.
Insiders who bought ACTU
- Daniel M. Schmitt President
Questions
Are insiders buying ACTU stock?
Yes. In the last 90 days, 1 open-market purchase was filed, worth $50k.
Who bought ACTU stock most recently?
Daniel M. Schmitt, President, bought 140,844 shares for $50k (Form 4 (opens sec.gov), filed Oct 29, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
Data as of Oct 29, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer